Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Aeras and Crucell announce Phase II clinical trial start in Kenya

September 22, 2010 12:31 am | by EurekAlert | News | Comments

(Aeras Global TB Vaccine Foundation) Aeras and Crucell announce the start of a Phase II clinical trial in infants of the jointly developed TB vaccine candidate, AERAS-402/Crucell Ad35. The trial will test the safety and efficacy of the TB vaccine candidate in infants previously vaccinated...

NIH celebrates 10 years of research into health disparities

September 21, 2010 1:32 pm | by EurekAlert | News | Comments

(NIH/National Heart, Lung and Blood Institute) The tenth anniversary of the Jackson Heart Study (JHS) will be observed on Sept. 23-24 in Jackson, Mississippi. The JHS is the largest study in history to investigate genetic factors that affect high blood pressure, heart and lung disease,...

New therapy found for lung and skin cancer, based on suicide gene E

September 21, 2010 12:31 pm | by EurekAlert | News | Comments

(University of Granada) This coliphage gene can induce death to cells transected with it. Scientists at the University of Granada have proven that this method is not only effective in vitro (using tumor cell cultures), but also in vivo, through the use of experimental animals in which...

Advertisement

ImmunoGen begins clinical tests of cancer treatment

September 21, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

ImmunoGen Inc. has begun clinical testing of its drug candidate SAR566658, co-developed with Paris pharmaceutical giant Sanofi-aventis, in treating ovarian, breast, cervical, lung and pancreatic cancers.

Nonin Medical to Introduce New Innovations at ERS 2010 Annual Congress

September 20, 2010 2:31 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Sept. 20 /- Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, today introduced new pulse oximetry products, a new clinical guidebook and a new European sales, distribution and customer service center at the European Respiratory...

Boston Scientific to buy privately held Asthmatx

September 20, 2010 6:45 am | by The Associated Press | News | Comments

Boston Scientific will buy privately held Asthmatx Inc. in a deal that could be worth more than $440 million, the medical device maker said Monday. Boston Scientific, which is based in Natick, Mass., said it will pay $193.5 million upfront in cash. It will then make additional payments of up to...

Boston Scientific to Acquire Asthmatx

September 20, 2010 4:33 am | by Boston Scientific | News | Comments

Asthmatx offers first FDA-approved non-drug procedure for the treatment of severe asthma

Childhood viral infection may be a cause of obesity

September 19, 2010 9:31 pm | by EurekAlert | News | Comments

(University of California -- San Diego) The emerging idea that obesity may have an infectious origin gets new support in a cross-sectional study by University of California, San Diego School of Medicine researchers who found that children exposed to a particular strain of adenovirus were...

Advertisement

Possible alternate therapy for adults with poorly controlled asthma

September 19, 2010 6:31 am | by EurekAlert | News | Comments

(NIH/National Heart, Lung and Blood Institute) A drug commonly used for the treatment of chronic obstructive pulmonary disease successfully treats adults whose asthma is not well-controlled on low doses of inhaled corticosteroids, reported researchers supported by the National Heart,...

Adding yoga to workout regime can improve health

September 18, 2010 7:31 pm | by Baylor College of Medicine | News | Comments

Implementing yoga into a workout routine can provide unique health benefits, said a Baylor College of Medicine physician and yoga enthusiast. "Yoga is a broad philosophy containing many different paths to achieve the goal of physical, mental and spiritual well-being," said Dr. Bobby...

Increasing Prevalence of Respiratory Diseases Drives Growth for Ventilators Market

September 17, 2010 7:47 am | News | Comments

Wellingborough (September 2010) – A new report from InMedica (www.in-medica.com) on the world market for ventilators and accessories, estimated that the total market was worth $2.3 billion in 2009.

Imbalanced diet and inadequate exercise may underlie asthma in children

September 16, 2010 9:34 am | by EurekAlert | News | Comments

(American Thoracic Society) Even children of a healthy weight who have an imbalanced metabolism due to poor diet or exercise may be at increased risk of asthma, according to new research, which challenges the widespread assumption that obesity itself is a risk factor for asthma.

Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research

September 16, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Sept. 16 /- Ascendant Neuro is pleased to announce the addition of Kenneth Alo, M.D., an internationally recognized specialist who has joined to further the advancement of the group's minimally invasive pain treatment techniques through the innovative use of neurostimulators ....

Advertisement

Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference

September 16, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., Sept. 16 /- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE ), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug...

FierceBiotech Names VentiRx Pharmaceuticals as One of the 'Fierce 15' Biotech Companies of 2010

September 15, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 15 /- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) candidates for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has been named to the annual...

Three Leading Sleep Solution Providers Choose Watermark Medical's Web-Enabled Home Sleep Testing Solutions

September 15, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

BOCA RATON, Fla., Sept. 15 /- Watermark Medical , Inc., a privately-held, medical products and services company servicing the sleep-disordered breathing market, has expanded the market reach of its Web-enabled in-home sleep apnea testing device through strategic alliances with three...

Radiation exposure poses similar risk of first and second cancers in atomic bomb survivors

September 14, 2010 9:34 pm | by EurekAlert | News | Comments

(Fred Hutchinson Cancer Research Center) The first large-scale study of the relationship between radiation dose and risk of multiple cancers among atomic bomb survivors in Hiroshima and Nagasaki, Japan, reveals a similar risk in the development of first and second subsequent cancers.

Reportlinker Adds Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

September 14, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 14 /- Reportlinker.com announces that a new market research report is available in its catalogue: Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 14 /- Palmetto Health Richland in Columbia—South Carolina's largest and most comprehensive healthcare resource, and Masimo (Nasdaq: MASI ) today jointly announced South Carolina's first installation of Masimo Patient SafetyNet, an advanced remote monitoring and...

Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 14 /- Cancer treatment experts today reported their experiences with early treatments using the new TrueBeam system from Varian Medical Systems (NYSE: VAR ), aimed at increasing the speed and precision of radiotherapy and radiosurgery treatments. Clinicians from...

New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Burness Communications) A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announces that these same drugs -- when used long term -- may be related to unusual but serious fractures of the thigh bone.

Study identifies underlying dysfunction of seemingly non-critical heart condition

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide...

Breakthrough in drug trial offers hope for heart attack patients

September 13, 2010 12:31 pm | by EurekAlert | News | Comments

(University of Sheffield) New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.

Zargis Signs Agreement to Provide Ontario Telemedicine Network With Remote Stethoscope Solution

September 10, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., Sept. 10 /- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (OTCQB: SPDE), today announced that it has signed an agreement with the Ontario Telemedicine Network (OTN) providing for the delivery and testing of Zargis' award-winning telemedicine...

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona

September 10, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 10 /- Varian Medical Systems (NYSE: VAR ) is spotlighting its new TrueBeam™ medical linear accelerator for fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading